Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE1
20 participants
INTERVENTIONAL
2011-12-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring of Hemodynamics in Heart Failure Patients by Intracardiac Impedance Measurement
NCT01711281
Acute Changes in Bioimpedance During Cardiac Resynchronization Therapy
NCT03640000
RESpiration deTection From Implanted Cardiac Devices in Subjects With Heart Failure (REST-HF)
NCT03087084
Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart Failure
NCT03494933
Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT
NCT00156728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Akern BIA101 and Custom Device
Impedance Measurement every 4 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients older than 18 years
* patients willing and able to give informed consent
Exclusion Criteria
* patients enrolled in a concurrent study that may confound the results of this study
* patients unable or unwilling to participate in study procedures
* patients who are pregnant
* patients who are mentally handicapped or legal incompetent
* patients who are dependent on investigator or sponsor
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic BRC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sebastian KG Maier, Prof.
Role: PRINCIPAL_INVESTIGATOR
Klinikum St. Elisabeth Straubing, Med. Klinik II, St.-Elisabeth-Str. 23, 94315 Straubing, Germany
Eva Goncalvesova, Prof.
Role: PRINCIPAL_INVESTIGATOR
NUSCH, Cardiac Surgery, Pod Krasnou horkou 1, 83348 Bratislava, Slovakia
Petr Neuzil, Prof.
Role: PRINCIPAL_INVESTIGATOR
Nemocnice Na Homolce, Cardiology, Roentgenova 2/37, 150 30 Praha 5, Czechia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nemocnice Na Homolce
Prague, , Czechia
Universitätsklinik Würzburg, Medizinische Klinik und Poliklinik I
Würzburg, Franken, Germany
NUSCH
Bratislava, , Slovakia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RAE00564
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.